STI571 (Glivec®) affects histamine release and intracellular pH after alkalinisation in HMC-1560, 816

Journal of Cellular Biochemistry

Volumn 103, Issue 3, 2008, Pages 865-876

  Löber, Kristin ^a   Alfonso, Amparo ^a   Escribano, Luis ^b   Botana, Luis M ^a  

^a Facultad de Veterinaria   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Alkalinisation; Calcium; Glivec; HMC 1560, 816; HMC 1560; Intracellular pH; Mast cells; Protein kinase C; STI571; Tyrosine kinase

Indexed keywords

12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; 2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; AMMONIUM CHLORIDE; CALCIUM ION; IMATINIB; IONOMYCIN; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; ACETOPHENONE DERIVATIVE; ALKALI; AMINE OXIDASE (COPPER CONTAINING); BENZOPYRAN DERIVATIVE; CALCIUM; ENZYME INHIBITOR; PIPERAZINE DERIVATIVE; PROTEIN KINASE INHIBITOR; PYRIMIDINE DERIVATIVE; ROTTLERIN;

ALKALINIZATION; ARTICLE; CALCIUM CELL LEVEL; CELL ACTIVATION; CELL PH; CONTROLLED STUDY; ENZYME ACTIVATION; EXOCYTOSIS; HISTAMINE RELEASE; HUMAN; HUMAN CELL; MAST CELL; MASTOCYTOSIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; APOPTOSIS; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CHEMISTRY; CYTOPLASM; DRUG DELIVERY SYSTEM; DRUG EFFECT; METABOLISM; PH; PHYSIOLOGY; SYSTEMIC MASTOCYTOSIS;

ACETOPHENONES; ALKALIES; AMINE OXIDASE (COPPER-CONTAINING); APOPTOSIS; BENZOPYRANS; CALCIUM; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CYTOPLASM; DRUG DELIVERY SYSTEMS; ENZYME INHIBITORS; EXOCYTOSIS; HISTAMINE RELEASE; HUMANS; HYDROGEN-ION CONCENTRATION; MAST CELLS; MASTOCYTOSIS, SYSTEMIC; PIPERAZINES; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; PROTEIN-TYROSINE KINASES; PYRIMIDINES; SIGNAL TRANSDUCTION;

EID: 39049130408     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21458     Document Type: Article

References (26)

1. Akin C, Metcalfe DD. 2004. Systemic mastocytosis. Annu Rev Med 55:419-432.
2. Akin C, Brockow K, D'Ambrosio C, Kirshenbaum AS, Ma Y, Longley BJ, Metcalfe DD. 2003. Effects of tyrosine kinase inhibitor STI571 on human mast cells bearing wild-type or mutated c-kit. Exp Hematol 31:686-692.
3. Alfonso A, Botana MA, Vieytes MR, Botana LM. 1994. Functional characterization of the Na(+)-H+ exchanger in rat mast cells: Crosstalks between different kinase pathways. Eur J Pharmacol 267:289-296.
4. Alfonso A, Botana MA, Vieytes MR, Botana LM. 1998. Sodium, PMA and calcium play an important role on intracellular pH modulation in rat mast cells. Cell Physiol Biochem 8:314-327.
5. Alfonso A, Cabado AG, Vieytes MR, Botana LM. 2000. Calcium-pH crosstalks in rat mast cells: Cytosolic alkalinization, but not intracellular calcium release, is a sufficient signal for degranulation. Br J Pharmacol 130:1809-1816.
6. Friis UG, Johansen T. 1996. Dual regulation of the Na+/H(+)-exchange in rat peritoneal mast cells: Role of protein kinase C and calcium on pHi regulation and histamine release. Br J Pharmacol 118:1327-1334.
7. Garcia-Montero AC, Jara-Acevedo M, Teodosio C, Sanchez ML, Nunez R, Prados A, Aldanondo I, Sanchez L, Dominguez M, Botana LM, Sanchez-Jimenez F, Sotlar K, Almeida J, Escribano L, Orfao A. 2006. KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: A prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients. Blood 108:2366-2372.
8. Gleixner KV, Mayerhofer M, Aichberger KJ, Derdak S, Sonneck K, Bohm A, Gruze A, Samorapoompichit P, Manley PW, Fabbro D, Pickl WF, Sillaber C, Valent P. 2005. PKC412 inhibits in vitro growth of neoplastic human mast cells expressing the D816V-mutated variant of KIT: Comparison with AMN107, imatinib, and cladribine (2CdA) and evaluation of cooperative drug effects. Blood 107:752-759.
9. Grynkiewicz G, Poenie M, Tsien RY. 1985. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 260: 3440-3450.
10. Heinrich MC, Griffith DJ, Druker BJ, Wait CL, Ott KA, Zigler A. 2000. Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor. Blood 96:925-932.
11. Kempna P, Reiter E, Arock M, Azzi A, Zingg JM. 2004. Inhibition of HMC-1 mast cell proliferation by vitamin E: Involvement of the protein kinase B pathway. J Biol Chem 279:50700-50709.
12. Linnekin D. 1999. Early signaling pathways activated by c-Kit in hematopoietic cells. Int J Biochem Cell Biol 31:1053-1074.
13. Ma Y, Zeng S, Metcalfe DD, Akin C, Dimitrijevic S, Butterfield JH, McMahon G, Longley BJ. 2002. The c-KIT mutation causing human mastocytosis is resistant to STI571 and other KIT kinase inhibitors; kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutations. Blood 99:1741-1744.
14. Pernas-Sueiras O, Alfonso A, Vieytes MR, Botana LM. 2005. Mast cell exocytosis can be triggered by ammonium chloride with just a cytosolic alkalinization and no calcium increase. J Cell Physiol 204:775-784.
15. Pernas-Sueiras O, Alfonso A, Vieytes MR, Botana LM. 2006a. PKC and cAMP positively modulate alkaline-induced exocytosis in the human mast cell line HMC-1. J Cell Biochem 99:1651-1663.
16. 2+-ATPase. J Cell Biochem 99:1397-1408.
17. Puceat M, Roche S, Vassort G. 1998. Src family tyrosine kinase regulates intracellular pH in cardiomyocytes. J Cell Biol 141:1637-1646.
18. Roskoski RJ. 2003. STI-571: An anticancer protein-tyrosine kinase inhibitor. Biochem Biophys Res Commun 309:709-717.
19. Shah NP, Lee FY, Luo R, Jiang Y, Donker M, Akin C. 2006. Dasatinib (BMS-354825) inhibits KITD816V, an imatinib-resistant activating mutation that triggers neoplastic growth in most patients with systemic mastocytosis. Blood 108:286-291.
20. Shore PA. 1971. The chemical determination of histamine. Methods Biochem Anal (Suppl):89-97.
21. Sundstrom M, Vliagoftis H, Karlberg P, Butterfield JH, Nilsson K, Metcalfe DD, Nilsson G. 2003. Functional and phenotypic studies of two variants of a human mast cell line with a distinct set of mutations in the c-kit protooncogene. Immunology 108:89-97.
22. Teofoli P, Frezzolini A, Puddu P, De Pita O, Mauviel A, Lotti T. 1999. The role of proopiomelanocortin-derived peptides in skin fibroblast and mast cell functions. Ann NY Acad Sci 885:268-276.
23. Thomas JA, Buchsbaum RN, Zimniak A, Racker E. 1979. Intracellular pH measurements in Ehrlich ascites tumor cells utilizing spectroscopic probes generated in situ. Biochemistry 18:2210-2218.
24. Valent P, Horny HP, Escribano L, Longley BJ, Li CY, Schwartz LB, Marone G, Nunez R, Akin C, Sotlar K, Sperr WR, Wolff K, Brunning RD, Parwaresch RM, Austen KF, Lennert K, Metcalfe DD, Vardiman JW, Bennett JM. 2001. Diagnostic criteria and classification of mastocytosis: A consensus proposal. Leuk Res 25:603-625.
25. Vilarino N, Vieytes MR, Vieites JM, Botana LM. 1999. Modulatory effect of HCO3- on rat mast cell exocytosis: Cross-talks between bicarbonate and calcium. Biochem Biophys Res Commun 260:71-79.
26. Yavuz AS, Lipsky PE, Yavuz S, Metcalfe DD, Akin C. 2002. Evidence for the involvement of a hematopoietic progenitor cell in systemic mastocytosis from single-cell analysis of mutations in the c-kit gene. Blood 100:661-665.